According to Kangtuo Medical's announcement, from May 11 to July 16, 2026, shares were reduced by a total of 717,333 shares through centralized bidding transactions, accounting for 0.88% of the total share capital. Its total shareholding ratio with those acting in concert fell from 53.67% to 52.80%, hitting an integer multiple of 1%. This change is due to the implementation of the holdings reduction plan, does not affect the proposed acquisition, and will not lead to changes in the controlling shareholders or actual controllers. As of the date of disclosure of the announcement, the holdings reduction plan has not yet been implemented.

According to Kangtuo Medical's announcement, from May 11 to July 16, 2026, shares were reduced by a total of 717,333 shares through centralized bidding transactions, accounting for 0.88% of the total share capital. Its total shareholding ratio with those acting in concert fell from 53.67% to 52.80%, hitting an integer multiple of 1%. This change is due to the implementation of the holdings reduction plan, does not affect the proposed acquisition, and will not lead to changes in the controlling shareholders or actual controllers. As of the date of disclosure of the announcement, the holdings reduction plan has not yet been implemented.